CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ipsen Biopharm against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICSOct 26, 2022
Combination-Based Treatment MethodNEKTAR THERAPEUTICSSep 27, 2018

Explore Ipsen Biopharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 18, 2024Suppression Of Bone Cancer-Induced Allodynia1
Jul 24, 2024Use Of Ultrasound To Guide Injection Of Non-Cytotoxic Protease1
May 5, 2021Combinations Of Liposomal Irinotecan, 5-Fu And Leucovorin For The Treatment Of Pancreatic Cancer3
Dec 9, 2020Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment1
Aug 12, 2020Methods For Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan And Oxaliplatin2
Feb 20, 2019Pharmaceutical Compositions Comprising Botulinum Neurotoxin1
May 3, 2017Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan1

Top competitors of Ipsen Biopharm

List of top competitors of Ipsen Biopharm based on patent oppositions.